Protective effects of curcumin against rat intestinal inflammation‑related motility disorders

Yao,Yang; Luo,Ranyuan; Xiong,Shu; Zhang,Chang; Zhang,Yukun

doi:10.3892/mmr.2021.12030

Protective effects of curcumin against rat intestinal inflammation‑related motility disorders

Authors:
- Yang Yao
- Ranyuan Luo
- Shu Xiong
- Chang Zhang
- Yukun Zhang
View Affiliations

Affiliations: Department of Basic Medicine, Chongqing Three Gorges Medical College, Chongqing 404120, P.R. China
Published online on: March 22, 2021 https://doi.org/10.3892/mmr.2021.12030
Article Number: 391
Copyright: © Yao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Intestinal inflammation frequently occurs alongside dysmotility, which is characterized by altered myosin light chain phosphorylation levels. Curcumin, an active component from the ginger family, is reported to confer anti‑inflammatory effects. However, the effects of curcumin on both diarrhea and constipation associated inflammation remains to be elucidated. The present study was designed to investigate the effects of curcumin on diarrhea and constipation and to determine the related mechanisms. Sprague‑Dawley rats were used to establish diarrhea and constipation models via intracolonic acetic acid (4%) instillation or cold water gavage for 2 weeks, respectively. Blood samples were collected to measure the serum levels of the cytokines TNF‑α and IL‑1β using ELISA kits. Western blotting was performed to measure NF‑κB, RhoA, Rho‑related kinase 2, phosphorylated MLC₂₀, phosphorylated myosin phosphorylated target subunit 1, 130k Da‑MLC kinase (MLCK), c‑kit tyrosine kinase protein expression, and reverse transcription‑quantitative PCR was conducted to measure MLCK expression levels. The results indicated that curcumin reversed the elevations in the pro‑inflammatory cytokines IL‑1β and TNF‑α by inhibiting the NF‑κB pathway in rats with diarrhea and constipation. The results also indicated that myosin light chain (MLC) phosphorylation in intestinal smooth muscle was positively and negatively associated with the motility of inflammation‑related diarrhea and constipation in rats, respectively. Curcumin significantly reversed the increased MLC phosphorylation in the jejunum of the rats with diarrhea, significantly enhanced the reductions in inflammatory mediators, including TNF‑α and IL‑1β, of rats with constipation and significantly ameliorated the related hyper‑motility and hypo‑motility in rats with both diarrhea and constipation. In conclusion, the potential roles of the MLC kinase, c‑kit tyrosine and Rho A/Rho‑associated kinase 2 pathways, which are involved in curcumin‑induced amelioration of inflammation‑related diarrhea and constipation, were explored in the present study. Results from the present study suggested that curcumin has potential therapeutic value for treating intestinal inflammation and inflammation‑related motility disorders.

View Figures

View References

1	Lestari ML and Indrayanto G: Curcumin. Profiles Drug Subst Excip Relat Methodol. 39:113–204. 2014. View Article : Google Scholar : PubMed/NCBI
2	Prasad S, Gupta SC, Tyagi AK and Aggarwal BB: Curcumin, a component of golden spice: From bedside to bench and back. Biotechnol Adv. 32:1053–1064. 2014. View Article : Google Scholar : PubMed/NCBI
3	Aggarwal BB, Yuan W, Li S and Gupta SC: Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric. Mol Nutr Food Res. 57:1529–1542. 2013. View Article : Google Scholar : PubMed/NCBI
4	Homayouni A, Amini M, Sohrabi M, Varshosaz J and Nokhodchi A: Curcumin nanoparticles containing poloxamer or soluplus tailored by high pressure homogenization using antisolvent crystallization. Int J Pharm. 562:124–134. 2019. View Article : Google Scholar : PubMed/NCBI
5	Ridzuan NRA, Rashid NA, Othman F, Budin SB, Hussan F and Teoh SL: Protective role of natural products in cisplatin-induced nephrotoxicity. Mini Rev Med Chem. 19:1134–1143. 2019. View Article : Google Scholar : PubMed/NCBI
6	Wong KE, Ngai SC, Chan KG, Lee LH, Goh BH and Chuah LH: Curcumin Nanoformulations for Colorectal Cancer: A Review. Front Pharmacol. 10:1522019. View Article : Google Scholar : PubMed/NCBI
7	Ozaki H, Hori M, Kinoshita K and Ohama T: Intestinal dysmotility in inflammatory bowel disease: Mechanisms of the reduced activity of smooth muscle contraction. Inflammopharmacology. 13:103–111. 2005. View Article : Google Scholar : PubMed/NCBI
8	Du X, Allwood G, Webberley KM, Inderjeeth AJ, Osseiran A and Marshall BJ: Noninvasive diagnosis of irritable bowel syndrome via bowel sound features: Proof of concept. Clin Transl Gastroenterol. 10:e000172019. View Article : Google Scholar : PubMed/NCBI
9	Ng QX, Soh AYS, Loke W, Venkatanarayanan N, Lim DY and Yeo WS: A Meta-analysis of the clinical use of curcumin for irritable bowel syndrome (IBS). J Clin Med. 7:2982018. View Article : Google Scholar
10	Goulart RA, Barbalho SM, Lima VM, Souza GA, Matias JN, Araújo AC, Rubira CJ, Buchaim RL, Buchaim DV, Carvalho ACA and Guiguer ÉL: Effects of the use of curcumin on ulcerative colitis and Crohn's disease: A systematic review. J Med Food. Nov 5–2020.(Epub of print). View Article : Google Scholar : PubMed/NCBI
11	Horii K, Ehara Y, Shiina T, Naitou K, Nakamori H, Horii Y, Shimaoka H, Saito S and Shimizu Y: Sexually dimorphic response of colorectal motility to noxious stimuli in the colorectum in rats. J Physiol. 2020.(Ahead of print). PubMed/NCBI
12	Chen D, Xiong Y, Wang L, Lv B and Lin Y: Characteristics of emodin on modulating the contractility of jejunal smooth muscle. Can J Physiol Pharmacol. 90:455–462. 2012. View Article : Google Scholar : PubMed/NCBI
13	Zou BC, Dong L, Wang Y, Wang SH and Cao MB: Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome. Chin Med J (Engl). 120:2069–2074. 2007. View Article : Google Scholar : PubMed/NCBI
14	La JH, Kim TW, Sung TS, Kang JW, Kim HJ and Yang IS: Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol. 9:2791–2795. 2003. View Article : Google Scholar : PubMed/NCBI
15	Peng HY, Yeh CM, Cheng JK, Chau YP, Ruan T, Chen GD, Hsieh MC, Lai CY and Lin TB: Acute uterine irritation provokes colonic motility via transient receptor potential A(1)-dependent spinal NR2B phosphorylation in rats. Anesthesiology. 120:436–446. 2014. View Article : Google Scholar : PubMed/NCBI
16	Qi DB and Li WM: Effects of electroacupuncture on expression of c-fos protein in the spinal dorsal horn of rats with chronic visceral hyperalgesia. Zhong Xi Yi Jie He Xue Bao. 10:1490–1496. 2012. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Ohama T, Hori M, Momotani E, Iwakura Y, Guo F, Kishi H, Kobayashi S and Ozaki H: Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-alpha and causes motility disorders. Am J Physiol Gastrointest Liver Physiol. 292:G1429–G1438. 2007. View Article : Google Scholar : PubMed/NCBI
19	Chen DP, Xiong YJ, Tang ZY, Yao QY, Ye DM, Liu SS and Lin Y: Characteristics of deslanoside-induced modulation on jejunal contractility. World J Gastroenterol. 18:5889–5896. 2012. View Article : Google Scholar : PubMed/NCBI
20	Kim HH, Kim DS, Kim SW, Lim SH, Kim DK, Shin TY and Kim SH: Inhibitory effects of Diospyros kaki in a model of allergic inflammation: Role of cAMP, calcium and nuclear factor-κB. Int J Mol Med. 32:945–951. 2013. View Article : Google Scholar : PubMed/NCBI
21	Zhang W, Sun J, Shen X, Xue Y, Yuan S and Wang X: Effect of PA-MSAH preprocessing on the expression of TLR-4-NF-κB pathway and inflammatory factors in the intestinal tract of rats with septic shock. Exp Ther Med. 17:2567–2574. 2019.PubMed/NCBI
22	Sun G, Xing C, Zeng L, Huang Y, Sun X and Liu Y: Flemingia philippinensis Flavonoids Relieve Bone Erosion and Inflammatory Mediators in CIA Mice by Downregulating NF-κB and MAPK Pathways. Mediators Inflamm. 2019:57902912019. View Article : Google Scholar : PubMed/NCBI
23	Xu Z, Liang H, Zhang M, Tao X, Dou D, Hu L and Kang T: Ardipusilloside-I stimulates gastrointestinal motility and phosphorylation of smooth muscle myosin by myosin light chain kinase. Korean J Physiol Pharmacol. 21:609–616. 2017. View Article : Google Scholar : PubMed/NCBI
24	Chang AN, Mahajan P, Knapp S, Barton H, Sweeney HL, Kamm KE and Stull JT: Cardiac myosin light chain is phosphorylated by Ca2+/calmodulin-dependent and -independent kinase activities. Proc Natl Acad Sci USA. 113:E3824–E3833. 2016. View Article : Google Scholar : PubMed/NCBI
25	Somlyo AP and Somlyo AV: Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 83:1325–1358. 2003. View Article : Google Scholar : PubMed/NCBI
26	Martelli L, Ragazzi E, di Mario F, Martelli M, Castagliuolo I, Dal Maschio M, Palu G, Maschietto M, Scorzeto M, Vassanelli S and Brun P: A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterol Motil. 19:668–674. 2007. View Article : Google Scholar : PubMed/NCBI
27	Der T, Bercik P, Donnelly G, Jackson T, Berezin I, Collins SM and Huizinga JD: Interstitial cells of cajal and inflammation-induced motor dysfunction in the mouse small intestine. Gastroenterology. 119:1590–1599. 2000. View Article : Google Scholar : PubMed/NCBI
28	Jo HJ, Kim N, Nam RH, Kang JM, Kim JH, Choe G, Lee HS, Park JH, Chang H, Kim H, et al: Fat deposition in the tunica muscularis and decrease of interstitial cells of Cajal and nNOS-positive neuronal cells in the aged rat colon. Am J Physiol Gastrointest Liver Physiol. 306:G659–G669. 2014. View Article : Google Scholar : PubMed/NCBI
29	Szałwińska P, Włodarczyk J, Spinelli A, Fichna J and Włodarczyk M: IBS-Symptoms in IBD patients-manifestation of concomitant or different entities. J Clin Med. 10:312020. View Article : Google Scholar
30	Kamiya T, Shikano M, Tanaka M, Ozeki K, Ebi M, Katano T, Hamano S, Nishiwaki H, Tsukamoto H, Mizoshita T, et al: Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: A pilot, randomized controlled study. Evid Based Complement Alternat Med. 2014:8281372014. View Article : Google Scholar : PubMed/NCBI
31	Yarandi SS, Hebbar G, Sauer CG, Cole CR and Ziegler TR: Diverse roles of leptin in the gastrointestinal tract: Modulation of motility, absorption, growth, and inflammation. Nutrition. 27:269–275. 2011. View Article : Google Scholar : PubMed/NCBI
32	Welch MG, Margolis KG, Li Z and Gershon MD: Oxytocin regulates gastrointestinal motility, inflammation, macromolecular permeability, and mucosal maintenance in mice. Am J Physiol Gastrointest Liver Physiol. 307:G848–G862. 2014. View Article : Google Scholar : PubMed/NCBI
33	Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA and Sartor RB: Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 163:3474–3483. 1999.PubMed/NCBI
34	Zhu T, Chen Z, Chen G, Wang D, Tang S, Deng H, Wang J, Li S, Lan J, Tong J, et al: Curcumin attenuates asthmatic airway inflammation and mucus hypersecretion involving a PPARγ-Dependent NF-κB signaling pathway in vivo and in vitro. Mediators Inflamm. 2019:49274302019. View Article : Google Scholar : PubMed/NCBI
35	Torres J, Ellul P, Langhorst J, Mikocka-Walus A, Barreiro-de Acosta M, Basnayake C, Ding NJS, Gilardi D, Katsanos K, Moser G, et al: European crohn's and colitis organisation topical review on complementary medicine and psychotherapy in inflammatory bowel disease. J Crohns Colitis. 13:673–685e. 2019. View Article : Google Scholar : PubMed/NCBI
36	Larmonier CB, Midura-Kiela MT, Ramalingam R, Laubitz D, Janikashvili N, Larmonier N, Ghishan FK and Kiela PR: Modulation of neutrophil motility by curcumin: Implications for inflammatory bowel disease. Inflamm Bowel Dis. 17:503–515. 2011. View Article : Google Scholar : PubMed/NCBI
37	Álvarez-Santos MD, Álvarez-González M, Estrada-Soto S and Bazán-Perkins B: Regulation of myosin light-chain phosphatase activity to generate airway smooth muscle hypercontractility. Front Physiol. 11:7012020. View Article : Google Scholar : PubMed/NCBI
38	Rajagopal S, Kumar DP, Mahavadi S, Bhattacharya S, Zhou R, Corvera CU, Bunnett NW, Grider JR and Murthy KS: Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway. Am J Physiol Gastrointest Liver Physiol. 304:G527–G535. 2013. View Article : Google Scholar : PubMed/NCBI
39	Moreno-Dominguez A, Colinas O, El-Yazbi A, Walsh EJ, Hill MA, Walsh MP and Cole WC: Ca²⁺ sensitization due to myosin light chain phosphatase inhibition and cytoskeletal reorganization in the myogenic response of skeletal muscle resistance arteries. J Physiol. 591:1235–1250. 2013. View Article : Google Scholar : PubMed/NCBI
40	Grassie ME, Moffat LD, Walsh MP and MacDonald JA: The myosin phosphatase targeting protein (MYPT) family: A regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ. Arch Biochem Biophys. 510:147–159. 2011. View Article : Google Scholar : PubMed/NCBI
41	Drumm BT, Rembetski BE, Messersmith K, Manierka MS, Baker SA and Sanders KM: Pacemaker function and neural responsiveness of subserosal interstitial cells of Cajal in the mouse colon. J Physiol. 598:651–681. 2020. View Article : Google Scholar : PubMed/NCBI
42	Somlyo AP and Somlyo AV: Smooth muscle: Excitation- contraction coupling, contractile regulation, and the cross-bridge cycle. Alcohol Clin Exp Res. 18:138–143. 1994. View Article : Google Scholar : PubMed/NCBI
43	Wei J, Li N, Xia X, Chen X, Peng F, Besner GE and Feng J: Effects of lipopolysaccharide-induced inflammation on the interstitial cells of Cajal. Cell Tissue Res. 356:29–37. 2014. View Article : Google Scholar : PubMed/NCBI
44	Fallahi F, Borran S, Ashrafizadeh M, Zarrabi A, Pourhanifeh MH, Khaksary Mahabady M, Sahebkar A and Mirzaei H: Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials. Mol Immunol. 130:20–30. 2020. View Article : Google Scholar : PubMed/NCBI
45	Qiao P, Ma J, Wang Y, Huang Z, Zou Q, Cai Z and Tang Y: Curcumin prevents neuroinflammation by inducing microglia to transform into the M2-phenotype via CaMKKβ-dependent activation of the AMP-activated protein kinase signal pathway. Curr Alzheimer Res. 17:735–752. 2020. View Article : Google Scholar : PubMed/NCBI
46	Bardak H, Uğuz AC and Bardak Y: Curcumin regulates intracellular calcium release and inhibits oxidative stress parameters, VEGF, and caspase-3/-9 levels in human retinal pigment epithelium cells. Physiol Int. 104:301–315. 2017. View Article : Google Scholar : PubMed/NCBI